Biodesix, Inc. (BDSX) NASDAQ

15.07

+0.31(+2.10%)

Updated at April 02 04:00PM

Currency In USD

Valuation

Market Cap51.35M
Enterprise Value105.21M
P/E Ratio-3.45
PEG Ratio-0.27
Price/Sales Ratio1.29
Price/Book Ratio-49.31
Enterprise/Revenue1.89
Enterprise/EBITDA-7.63

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin-0.4
Operating Margin-0.31

Management Effectiveness

Return On Assets-0.4
Return On Equity-17.61

Income Statement

Revenue88.5M
Revenue/Share10.97
Gross Profit66.59M
EBITDA-21.88M
Net Income-35.27M
Diluted EPS-4.67

Balance Sheet

Total Cash18.99M
Total Cash/Share2.35
Total Debt72.85M
Total Debt/Equity-29.56
Current Ratio1.86
Book Value Per Share-0.31

Price History

52-Week Change26.75
52-Week High20.21
52-Week Low3.44
Moving Average 50 Days13.75
Moving Average 200 Days8.99

Statistics

Average Volume1.45M
Shares Outstanding7.55M
% Held by Institutions17.9

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateSeptember 15, 2025